Henschel Quoted on In re: Kubin

06 April 2009 IP Law360 News

Foley Partner Ric Henschel was quoted in an article that appeared on IP Law360 on April 6, 2009 titled “Fed Circ. Rejects Amgen Bid For DNA Patent.” Henschel provides insight into a federal appeals court decision to uphold the U.S. Patent and Trademark Office’s rejection of a DNA patent application filed by Amgen Inc., adding that the ruling was neither a clear nor satisfying outcome for the biotechnology community.


CMS Proposes Enhanced Scrutiny over Medicaid Supplemental Payments
20 November 2019
Health Care Law Today
The Purpose of a Corporation
November 2019
Legal News: Business Law
Should This Be a "Mobility" Industry Blog?
19 November 2019
Dashboard Insights
Data Processing Patent Eligibility: Federal Circuit Finds Claims Eligible in KPN v. Gemalto
19 November 2019
IP Litigation Current
PATH Summit 2019
18-20 December 2019
Arlington, VA
Madison CLE Days
18-19 December 2019
Madison, WI
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
HFMA MA-RI Annual Compliance Update
12 December 2019
Boston, MA